Patents Assigned to NATIONAL INSTITUTES OF HEALTH (NIH), (DHHS), U.S. GOVERNMENT
  • Methods of determining patient populations amenable to immunomodulatory treatment of cancer
    Patent number: 11215616
    Abstract: The disclosure provides methods of determining patient populations amenable or suitable for immunomodulatory treatment of disease such as cancer by measuring the relative or absolute levels of T-cell sub-populations correlated with disease such as cancer.
    Type: Grant
    Filed: April 8, 2016
    Date of Patent: January 4, 2022
    Assignee: NATIONAL INSTITUTES OF HEALTH (NIH), (DHHS), U.S. GOVERNMENT
    Inventors: Lawrence Fong, Serena Kwek MacPhee, Jera Lewis